Sidera Bio ApS
Core data
Name | Sidera Bio ApS |
Address | Fruebjergvej 3, 2100, København Ø |
Founded | Oct 19, 2023 |
Employees (CVR) | 6 |
Locations (P-units) | 1View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | Sidera Bio ApS |
Address | Fruebjergvej 3, 2100, København Ø |
Founded | Oct 19, 2023 |
Employees (CVR) | 6 |
Locations (P-units) | 1View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of Sidera Bio ApS
Description
The Company's purpose is research, development, production and sale of pharmaceuticals and other related business areas at the discretion of the board of directors.
Financials
| Reporting period | 2025EUR | |
|---|---|---|
| Gross profit | -5,287,281 | |
| Profit before tax | -7,661,559 | |
| Net income | -6,924,629 | |
| Total assets | 88,858,903 | |
| Equity | 85,864,083 | |
| Avg. employees | 4 | |
2024–2025 Unlock financial history | ||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Mads Peter Hemmingsen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Peter Høngård Andersen | Roles Board | TitlesFORMAND |
| Keld Flintholm Jørgensen | Roles Management | TitlesADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| KPMG | AuditorSimon Vinberg Andersen | RoleState Authorised Public Accountant | FromJul 1, 2026 |
| KPMG | Auditor— | RoleStatsautoriseret Revisionspartnerselskab | FromJul 1, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
Unknown Other Participant | Ownership25–33.32 % | Voting rights25 % | FromNov 18, 2025 |
| Ownership15–19.99 % | Voting rights15 % | FromNov 18, 2025 | |
Unknown Other Participant | Ownership15–19.99 % | Voting rights15 % | FromNov 18, 2025 |
Unknown Other Participant | Ownership10–14.99 % | Voting rights10 % | FromNov 18, 2025 |
Unknown Other Participant | Ownership5–9.99 % | Voting rights5 % | FromJan 12, 2026 |
Unknown Other Participant | Ownership5–9.99 % | Voting rights5 % | FromNov 18, 2025 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇳🇱Forbion Ventures Fund VI Coöperatief U.A. | Ownership through Direct | 25–33.32 % |
| NOVO NORDISK FONDEN | Ownership through | 15–19.99 % |
| 🇺🇸RA Capital Healthcare Fund, L.P. | Ownership through Direct | 15–19.99 % |
| 🇳🇱Coöperatieve Gilde Healthcare VG VI U.A. | Ownership through Direct | 10–14.99 % |
| 🇺🇸Samsara BioCapital, L.P. | Ownership through Direct | 5–9.99 % |
| 🇳🇱Stichting Juridisch eigendom ForCal I | Ownership through Direct | 5–9.99 % |